Table 8.
Univariate analysis of clinical infection characteristics of patients with different types.
| Parameter | ST11 group (n = 38) | Non-ST11 group (n = 20) | T/F值 | P Value |
|---|---|---|---|---|
| Age (year) | 65.25 ± 7.34 | 68.37 ± 6.21 | 1.619 | 0.111 |
| Sex (male/female) | 28/10 | 15/5 | 0.012 | 0.913 |
| Diabetes | 10 (26.32%) | 6 (30.00%) | 0.089 | 0.765 |
| Cardiovascular disease | 14 (36.84%) | 5 (25.00%) | 0.834 | 0.361 |
| Tumor | 7 (18.42%) | 5 (25.00%) | 0.345 | 0.557 |
| ICU stay | 34 (89.47%) | 10 (50.00%) | 11.150 | 0.001 |
| Mechanical ventilation | 35 (92.11%) | 12 (60.00%) | 8.788 | 0.003 |
| Tracheostomy | 21 (55.26%) | 13 (65.00%) | 0.512 | 0.474 |
| Venipuncture | 22 (57.89%) | 15 (75.00%) | 1.660 | 0.198 |
| Indwelling the catheter | 20 (52.63%) | 11 (55.00%) | 0.030 | 0.864 |
| Drainage tube | 25 (65.79%) | 7 (35.00%) | 5.023 | 0.025 |
| Prior antimicrobial use | ||||
| Carbapenems | 22 (57.89%) | 16 (80.00%) | 2.834 | 0.092 |
| Third-generation cephalosporins | 33 (86.84%) | 20 (100%) | 2.880 | 0.090 |